News|Videos|October 7, 2026

Why Pharma Is Automating for Resilience

At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.

According to Garrett Freeman, sales director at Swisslog, the business case for automation in pharmaceutical supply chains has changed. Speaking with Pharmaceutical Commerce at LogiPharma USA 2026, Freeman says that before the COVID-19 pandemic, the main drivers for automation were efficiency and labor reduction. Now, he says, companies want "resilient, redundant supply chains" while also expanding overall network capacity, a theme he heard echoed across the conference.

Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.